MYC and Burkitt lymphoma: An exon-specific RT-qPCR assay using two pairs of Burkitt’s lymphoma cell lines (CA46 and RAJI), devised by Brooks group, allowed us to evaluate whether G4 ligands directly act for c-MYC G4 or not in cells [93,94].